About
PharmaEssentia is a Taiwanese biopharmaceutical company that develops therapies for chronic blood cancers, including myeloproliferative neoplasms, with focus on novel interferon immunotherapies and treatments targeting the root cause of diseases like polycythemia vera.
Explore PharmaEssentia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.